Biosimilar Development Program
Autoimmune Diseases (e.g., Rheumatoid Arthritis)
PreclinicalActive
Key Facts
Indication
Autoimmune Diseases (e.g., Rheumatoid Arthritis)
Phase
Preclinical
Status
Active
About Guangzhou Baiyunshan Pharmaceutical Holdings
Baiyunshan's mission is to leverage its dual heritage in Traditional Chinese Medicine and modern pharmaceuticals to become a global leader in integrated healthcare. Its key achievements include establishing one of China's most recognized pharmaceutical brands, building a diversified portfolio with numerous blockbuster TCM formulas and generic drugs, and operating a massive, vertically integrated supply chain. The company's strategy focuses on deepening its TCM scientific validation, expanding its innovative and generic chemical drug pipeline, and capitalizing on supportive national healthcare policies to drive sustainable growth.
View full company profileTherapeutic Areas
Other Autoimmune Diseases (e.g., Rheumatoid Arthritis) Drugs
| Drug | Company | Phase |
|---|---|---|
| Biosimilar Adalimumab | Strides Pharma | Development |